YAP1 and osteosarcoma: In fact, simvastatin has been demonstrated to exert antimetastatic and cytotoxic effects in osteosarcoma [255,256], at least in part by the downregulation of YAP/TAZ/TEAD target genes CYR61 and CTGF [257,258].